Welcome to Medications.com
Youre adding a drug to your cabinet. Login or Signup to complete this action, or Cancel.

Japan's Eisai Wins US FDA Priority Review for Aciphex Drug - Bloomberg

The FDA will review the use of Aciphex for short-term treatments of up to 8 weeks for gastroesophageal reflux disease in patients aged 12 to 16, ...

http://www.bloomberg.com/apps/new... | Posted: Fri Feb 29 21:22:36 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea